We are live on ! Find out more
LENZ

LENZ Therapeutics
LENZ

60 hedge funds and large institutions have $587M invested in LENZ Therapeutics in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

18% more funds holding

Funds holding: 51 → 60 (+9)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

0.63% more ownership

Funds ownership: 8.21% → 8.85% (+0.63%)

40% less capital invested

Capital invested by funds: $981M → $587M (-$394M)

75% less funds holding in top 10

Funds holding in top 10: 4 → 1 (-3)

Holders
60
Holders Change
+9
Holders Change %
+17.65%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
29
Increased
12
Reduced
11
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$52.6M
2
BlackRock
BlackRock
New York
+$17.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.1M
4
SFM
Sphera Funds Management
Israel
+$10.7M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$8.6M

Top Sellers

Rank Fund Capital Flow
1
SM
SB Management
United Arab Emirates
-$30.5M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.22M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.2M
4
Goldman Sachs
Goldman Sachs
New York
-$4.24M
5
SCM
Suvretta Capital Management
New York
-$3.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$48K +$62.5K +422 New
UBS Group
52
UBS Group
Switzerland
$41K +$53K +358 New
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$32K +$39.8K +269 +5,380%
Citigroup
54
Citigroup
New York
$31K +$40K +270 New
Legal & General Group
55
Legal & General Group
United Kingdom
$25K +$32.1K +217 New
Osaic Holdings
56
Osaic Holdings
Arizona
$22K +$28K +189 New
AIP
57
Ameritas Investment Partners
Nebraska
$20K +$26.4K +178 New
TRCT
58
Tower Research Capital (TRC)
New York
$11K +$14.4K +97 New
FDCDDQ
59
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.28K +$4.29K +29 New
APA
60
American Portfolios Advisors
New York
$328 +$444 +3 New
SM
61
SB Management
United Arab Emirates
– -$30.5M -141,915 Closed
Adage Capital Partners
62
Adage Capital Partners
Massachusetts
– -$9.22M -42,857 Closed
SCM
63
Suvretta Capital Management
New York
– -$3.84M -17,857 Closed
Blackstone Inc
64
Blackstone Inc
New York
– -$2.31M -10,714 Closed
LP
65
LMR Partners
United Kingdom
– -$2.15M -10,000 Closed
MIM
66
Monashee Investment Management
Massachusetts
– -$1.84M -8,571 Closed
PCM
67
Pinz Capital Management
New York
– -$1.61M -7,506 Closed
ACM
68
Asymmetry Capital Management
California
– -$1.57M -7,291 Closed
Squarepoint
69
Squarepoint
New York
– -$1.23M -5,714 Closed
MWNA
70
Marshall Wace North America
New York
– -$1.13M -5,235 Closed
Alyeska Investment Group
71
Alyeska Investment Group
Illinois
– -$922K -4,286 Closed
DKCM
72
Davidson Kempner Capital Management
New York
– -$768K -3,571 Closed
Voloridge Investment Management
73
Voloridge Investment Management
Florida
– -$615K -2,857 Closed
Balyasny Asset Management
74
Balyasny Asset Management
Illinois
– -$591K -2,747 Closed
Jane Street
75
Jane Street
New York
– -$468K -2,175 Closed
1 2
3
4

LENZ Hedge Fund Activity: Q3 2021 in Review

60 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in LENZ Therapeutics (LENZ) for Q3 2021, worth a combined $587M — down 40% from $981M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LENZ positions and 20 closed out — a net gain of 9 holders — while 12 added to existing stakes and 11 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $52.6M. The largest seller was SB Management, exiting entirely with an estimated $30.5M sold.

  • 60 institutional investors held LENZ Therapeutics (LENZ) as of Q3 2021, up from 51 in Q2 2021.
  • Funds reported $587M of LENZ Therapeutics stock for Q3 2021, down 40% quarter-over-quarter.
  • 29 funds opened new LENZ Therapeutics positions in Q3 2021 and 20 closed out, a net change of +9 holders.
  • The largest LENZ Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $52.6M added.
  • The largest LENZ Therapeutics seller in Q3 2021 was SB Management, an estimated $30.5M sold.

Based on aggregated 13F filings for Q3 2021.